Article Text

AB1029 Genistein prevents quality of life osteopenic post-menopausal womens: A 2-year randomized, double-blind, controlled-study
  1. M. Atteritano,
  2. G. Miceli,
  3. G. Bagnato,
  4. D. Sangari,
  5. R. Talotta,
  6. A. Tamburello,
  7. S. Morgante,
  8. G. Bagnato
  1. Dep. of Internal Medicine, Unit of Rheumatology, University of Messina, Messina, Italy


Background Postmenopausal estrogen decline is implicated in several age-related physical and psychological changes in women, including decreases in perceived quality of life (QoL). A number of trials with hormone therapy showed beneficial effects of the intervention on parameters of quality of life. However, because of known or suspected serious side-effects of conventional hormone therapy there is a need for alternatives

Objectives The goal of this study was to evaluate the effect of genistein treatment on health-related quality of life in osteopenic postmenopausal women.

Methods We conducted a double-blind randomized placebo-controlled trial with phytoestrogen genistein 54 mg or placebo for 2 year. For this trial, we recruited 288 postmenopausal women aged 49 to 67 years. At baseline, after 1 year and at final visit, participants filled in the Short Form of 36 questions (SF-36), the Questionnaire on Life Satisfaction Modules (QLSM), and the Zung Self-Rating Depression Scale (ZSDS).

Results For the placebo group scores on all dimensions of the SF-36 and the QLSM decreased after 1 year and after 2 years. The genistein group showed increases on all dimensions of the SF-36 and the QLSM. There were however statistically significant differences in changes of scores between the two intervention groups. For the ZSDS similarly, significant differences were found between the groups.

Conclusions In conclusion, the findings in this randomized trial do support the presence of a marked effect of phytoestrogen genistein on quality of life (health status, life satisfaction, and depression) in osteopenic postmenopausal women.

  1. Herschbach P, Henrich G, Strasburger CJ, et al. Development and psychometric properties of a disease-specific quality of life questionnaire for adult patients with growth hormone deficiency. Eur J Endocrinol 2001;1453:255–265.

  2. Blumel JE, Castelo-Branco C, Binfa L, et al. Quality of life after the menopause: a population study. Maturitas 2000;341:17–23.

  3. Ravnikar VA. Compliance with hormone replacement therapy: are women receiving the full impact of hormone replacement therapy preventive health benefits? Women Health Iss 1992;22:75–80.

  4. Writing Group for the Women’s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288 (3):321–333

  5. Zung, WW (1965). A self-rating depression scale. Archives of General Psychiatry 12: 63–70.

Disclosure of Interest None Declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.